✦ LIBER ✦

P109 Efficacy and safety of a 3-monthly depot formulation of degarelix compared with goserelin in prostate cancer

✍ Scribed by Tombal, B.; Tammela, T.L.J.; Wolff, J.M.; Payne, H.; Crawford, E.D.; Shore, N.; Gittelman, M.C.; Olesen, T.K.; Persson, B.; Klotz, L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP-22.13: A comparative head on efficacy

✍ R. Sood; V. Jain 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Efficacy and safety of androgen deprivat

✍ J. de la Rosette; R. Davis III; D. Frankel; T. Kold Olesen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 817 KB

The efficacy and safety of degarelix: a

✍ Laurence Klotz; Laurent Boccon-Gibod; Neal D. Shore; Cal Andreou; Bo-Eric Persso 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

MP-18.07: Phase III Efficacy and Safety

✍ A. Kaisary; C. Savulsky; N. Shore; G. Karlin; R. Mis; C. Leuratti; M. Marberger 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 128 KB

UP.34: A Comparative Head-On Efficacy St

✍ R. Sood; S. Kathuria; H. Ahmad; M. Ahir 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Re: The Efficacy and Safety of Degarelix

✍ Dieter Jocham; Christian Doehn 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 112 KB